Amunix Pharmaceuticals Funding & Investors
Amunix Inc. is a pharmaceutical company. The Company focuses on therapeutic drugs which offer an alternative to antibodies and small molecules. Amunix also concentrates on protein design and the discovery research process.
amunix.comTotal Amount Raised: $190,000,000
Amunix Pharmaceuticals Funding Rounds
Series B
$117,000,000
Series B Investors
Polaris PartnersAvidity PartnersBain Capital Life SciencesOmega FundsArrowMark PartnersClough Capital PartnersVenrock Healthcare Capital PartnersCaaS Capital ManagementBlackRockViking Global InvestorsRedmile GroupFranklin ResourcesFrazier ManagementLongitude CapitalHenderson Global InvestorsCasdin CapitalSeries A
$73,000,000
Series A Investors
Polaris PartnersRedmile GroupTwo RiverFrazier ManagementVenrockOmega FundsLongitude CapitalDelian CapitalCasdin Capital
Funding info provided by Diffbot.